# FDA recall D-0930-2023

> **SterRx, LLC** · Class II · drug recall initiated 2023-07-07.

## Product

Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL Single Dose bag, packaged in 1000 mL x 6 units per case, SterRx, 141 Idaho Ave., Plattsburgh, NY  12903, NDC 70324-326-01.

## Reason for recall

Lack of Assurance of Sterility

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0930-2023
- **Recalling firm:** SterRx, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-07-07
- **Report date:** 2023-07-26
- **Termination date:** 2024-07-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Plattsburgh, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0930-2023

## Citation

> AI Analytics. FDA recall D-0930-2023. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0930-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*